Menu
Recruiting NCT06586424

The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction

Observational ST-segment Elevation Myocardial Infarction (STEMI)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Anion gap.
Who it may be relevant to
Registry conditions: ST-segment Elevation Myocardial Infarction (STEMI). Basic parameters: 18 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Indonesia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study aims to evaluate the prognostic value of the anion gap in predicting major adverse cardiovascular events among patients with ST-segment elevation myocardial infarction. Researchers will collect information based on hospital registry as secondary data of in patient who had diagnosed as ST-segment elevation myocardial infarction and underwent primary percutaneous coronary intervention. The data consist of demographic data, clinical presentation, laboratory, and angiography result were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.

Interventions

  • Diagnostic test Anion gap
    Patient was taken blood examination before PPCI

Primary outcome measures

  • Major Adverse Cardiovascular Events (MACE) [Time frame: During hospitalization, up to 1 weeks]
Secondary outcome measures (6)
  • Incidence of mortality [Time frame: During hospitalization, up to 1 weeks]
  • Incidence of reinfarction [Time frame: During hospitalization, up to 1 weeks]
  • Incidence of stroke [Time frame: During hospitalization, up to 1 weeks]
  • Incidence of lethal arrhythmia [Time frame: During hospitalization, up to 1 weeks]
  • Incidence of acute lung oedema [Time frame: During hospitalization, up to 1 weeks]
  • Incidence of cardiogenic shock [Time frame: During hospitalization, up to 1 weeks]

Eligibility criteria

Inclusion criteria

  • Adults with 18 - 70 years old with diagnosis of STEMI who underwent PPCI

Exclusion criteria

  • History of heart failure due to any causes
  • Cardiogenic shock before PPCI
  • Any infection at the time of presentation
  • Pregnant woman
  • Other causes of high anion gap levels such as chronic kidney disease, metabolic acidosis, etc

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-control

Study locations

Indonesia · 1 center
  • Dr. Kariadi Central General Hospital — Semarang

Identifiers

NCT: NCT06586424 · Undip_Kardio 2

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗